Tysabri® immunogenicity test

Alphabetical Test listing

Tysabri® immunogenicity test-994

  
Tysabri® immunogenicity test
  
994
  
LAB994
  
MSO
  
Anti-Tysabri (Natalizumab) Ab
Natalizumab immunogenicity test
  

New drugs such as Tysabri® offer highly specific and effective therapy for Multiple sclerosis patients. However, Tysabri® loses effectiveness when patients develop antibodies to the drug. Detecting these antibodies early allows healthcare providers the opportunity to prescribe alternative therapy and avoid the cost associated with failed therapy.

  
Serum
  
  
1.0 mL
  
  1. Allow to clot for 30 minutes.
  2. Spin, separate and freeze within 1 hour of sample collection.
  
  

Frozen (preferred) - 2 weeks

Refrigerated (OK) - 2 weeks

  
Viracor Eurofins (30040) via LabCorp (829191): R-NX
  
Batched
  
5 - 7 days
  

Enzyme-linked immunosorbent assay (ELISA)

  

Negative

  
83516
  
No
  
Result SOLOINC
  
05/22/2019
  
05/22/2019